Necroptosis, with three major components including RIPK1, RIPK3, and mixed lineage kinase domain‐like protein (MLKL), has been immensely recently investigated in various liver diseases such as NAFLD (Sun et al. 2024; Xinyu et al. 2023). Here, MLKL is linked to metabolic dysfunction-associated steatotic liver disease.